Literature DB >> 33592581

Global incidence and mortality of breast cancer: a trend analysis.

Junjie Huang1, Paul Sf Chan1, Veeleah Lok1, Xiao Chen1, Hanyue Ding1, Yinzi Jin2, Jinqiu Yuan3, Xiang-Qian Lao1,4, Zhi-Jie Zheng2, Martin Cs Wong1,2,5.   

Abstract

This study aimed to evaluate the global incidence and mortality trends of breast cancer among females by region and age in the past decade. We retrieved country-specific incidence and mortality data from the Global Cancer Observatory up to 2018 and Cancer Incidence in Five Continents volumes I-XI, the Nordic Cancer Registries, the Surveillance, Epidemiology, and End Results, and WHO mortality database up to 2016. The temporal patterns were using Average Annual Percent Change (AAPC) with the 95% confidence interval (CI) by joinpoint regression analysis. Most countries showed an increasing trend in incidence. For the older population aged ≥ 50 years, Japan (5.63, 4.90-6.36), Slovakia (3.63, 3.03-4.22), China (2.86, 2.00-3.72) reported the most prominent increase. For young females (<50 years), Japan (AAPC=3.81, 95% CI=2.71-4.93), Germany (AAPC=2.60, 95% CI=1.41-3.81) and Slovakia (1.91, 1.13-2.69) reported the most drastic rise. Similarly, 12 countries showed an incidence increase among women aged <40 years. As for mortality, the Philippines (4.36, 3.65-5.07), Thailand (4.35, 3.12-5.59), Colombia (0.75, 0.08-1.42), and Brazil (0.44, 0.19-0.68) reported a significant increase. The disease burden of breast cancer showed an increasing trend in a large number of populations. More preventive efforts are recommended for these countries. Further research should explore the underlying reasons for these epidemiological trends.

Entities:  

Keywords:  breast cancer; epidemiology; incidence; mortality; trend analysis

Mesh:

Year:  2021        PMID: 33592581      PMCID: PMC7950292          DOI: 10.18632/aging.202502

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  38 in total

1.  Words of Wisdom: re: international variation in prostate cancer incidence and mortality rates.

Authors:  Hidetoshi Kuruma; Shin Egawa
Journal:  Eur Urol       Date:  2013-03       Impact factor: 20.096

Review 2.  The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality.

Authors:  Danny R Youlden; Susanna M Cramb; Nathan A M Dunn; Jennifer M Muller; Christopher M Pyke; Peter D Baade
Journal:  Cancer Epidemiol       Date:  2012-03-27       Impact factor: 2.984

Review 3.  Central obesity and breast cancer risk: a systematic review.

Authors:  M Harvie; L Hooper; A H Howell
Journal:  Obes Rev       Date:  2003-08       Impact factor: 9.213

4.  Epidemiology and prognosis of breast cancer in young women.

Authors:  Hussein A Assi; Katia E Khoury; Haifa Dbouk; Lana E Khalil; Tarek H Mouhieddine; Nagi S El Saghir
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 5.  Breast Cancer Epidemiology and Risk Factors.

Authors:  Kristin Rojas; Ashley Stuckey
Journal:  Clin Obstet Gynecol       Date:  2016-12       Impact factor: 2.190

6.  The incidence of breast cancer in Canada 1971-2015: trends in screening-eligible and young-onset age groups.

Authors:  Emily Heer; Yibing Ruan; Nicole Mealey; May Lynn Quan; Darren R Brenner
Journal:  Can J Public Health       Date:  2020-03-06

7.  Global patterns and trends in colorectal cancer incidence and mortality.

Authors:  Melina Arnold; Mónica S Sierra; Mathieu Laversanne; Isabelle Soerjomataram; Ahmedin Jemal; Freddie Bray
Journal:  Gut       Date:  2016-01-27       Impact factor: 23.059

8.  Differences in Incidence and Mortality Trends of Colorectal Cancer Worldwide Based on Sex, Age, and Anatomic Location.

Authors:  Martin C S Wong; Junjie Huang; Veeleah Lok; Jingxuan Wang; Franklin Fung; Hanyue Ding; Zhi-Jie Zheng
Journal:  Clin Gastroenterol Hepatol       Date:  2020-02-21       Impact factor: 11.382

9.  The Burden and Trends of Breast Cancer From 1990 to 2017 at the Global, Regional, and National Levels: Results From the Global Burden of Disease Study 2017.

Authors:  Peng Ji; Yue Gong; Ming-Liang Jin; Xin Hu; Gen-Hong Di; Zhi-Ming Shao
Journal:  Front Oncol       Date:  2020-05-12       Impact factor: 6.244

10.  Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study.

Authors:  Christina Fitzmaurice; Tomi F Akinyemiju; Faris Hasan Al Lami; Tahiya Alam; Reza Alizadeh-Navaei; Christine Allen; Ubai Alsharif; Nelson Alvis-Guzman; Erfan Amini; Benjamin O Anderson; Olatunde Aremu; Al Artaman; Solomon Weldegebreal Asgedom; Reza Assadi; Tesfay Mehari Atey; Leticia Avila-Burgos; Ashish Awasthi; Huda Omer Ba Saleem; Aleksandra Barac; James R Bennett; Isabela M Bensenor; Nickhill Bhakta; Hermann Brenner; Lucero Cahuana-Hurtado; Carlos A Castañeda-Orjuela; Ferrán Catalá-López; Jee-Young Jasmine Choi; Devasahayam Jesudas Christopher; Sheng-Chia Chung; Maria Paula Curado; Lalit Dandona; Rakhi Dandona; José das Neves; Subhojit Dey; Samath D Dharmaratne; David Teye Doku; Tim R Driscoll; Manisha Dubey; Hedyeh Ebrahimi; Dumessa Edessa; Ziad El-Khatib; Aman Yesuf Endries; Florian Fischer; Lisa M Force; Kyle J Foreman; Solomon Weldemariam Gebrehiwot; Sameer Vali Gopalani; Giuseppe Grosso; Rahul Gupta; Bishal Gyawali; Randah Ribhi Hamadeh; Samer Hamidi; James Harvey; Hamid Yimam Hassen; Roderick J Hay; Simon I Hay; Behzad Heibati; Molla Kahssay Hiluf; Nobuyuki Horita; H Dean Hosgood; Olayinka S Ilesanmi; Kaire Innos; Farhad Islami; Mihajlo B Jakovljevic; Sarah Charlotte Johnson; Jost B Jonas; Amir Kasaeian; Tesfaye Dessale Kassa; Yousef Saleh Khader; Ejaz Ahmad Khan; Gulfaraz Khan; Young-Ho Khang; Mohammad Hossein Khosravi; Jagdish Khubchandani; Jacek A Kopec; G Anil Kumar; Michael Kutz; Deepesh Pravinkumar Lad; Alessandra Lafranconi; Qing Lan; Yirga Legesse; James Leigh; Shai Linn; Raimundas Lunevicius; Azeem Majeed; Reza Malekzadeh; Deborah Carvalho Malta; Lorenzo G Mantovani; Brian J McMahon; Toni Meier; Yohannes Adama Melaku; Mulugeta Melku; Peter Memiah; Walter Mendoza; Tuomo J Meretoja; Haftay Berhane Mezgebe; Ted R Miller; Shafiu Mohammed; Ali H Mokdad; Mahmood Moosazadeh; Paula Moraga; Seyyed Meysam Mousavi; Vinay Nangia; Cuong Tat Nguyen; Vuong Minh Nong; Felix Akpojene Ogbo; Andrew Toyin Olagunju; Mahesh Pa; Eun-Kee Park; Tejas Patel; David M Pereira; Farhad Pishgar; Maarten J Postma; Farshad Pourmalek; Mostafa Qorbani; Anwar Rafay; Salman Rawaf; David Laith Rawaf; Gholamreza Roshandel; Saeid Safiri; Hamideh Salimzadeh; Juan Ramon Sanabria; Milena M Santric Milicevic; Benn Sartorius; Maheswar Satpathy; Sadaf G Sepanlou; Katya Anne Shackelford; Masood Ali Shaikh; Mahdi Sharif-Alhoseini; Jun She; Min-Jeong Shin; Ivy Shiue; Mark G Shrime; Abiy Hiruye Sinke; Mekonnen Sisay; Amber Sligar; Muawiyyah Babale Sufiyan; Bryan L Sykes; Rafael Tabarés-Seisdedos; Gizachew Assefa Tessema; Roman Topor-Madry; Tung Thanh Tran; Bach Xuan Tran; Kingsley Nnanna Ukwaja; Vasiliy Victorovich Vlassov; Stein Emil Vollset; Elisabete Weiderpass; Hywel C Williams; Nigus Bililign Yimer; Naohiro Yonemoto; Mustafa Z Younis; Christopher J L Murray; Mohsen Naghavi
Journal:  JAMA Oncol       Date:  2018-11-01       Impact factor: 31.777

View more
  11 in total

1.  Patients with Invasive Lobular Carcinoma Show a Significant Increase in IRS-4 Expression Compared to Infiltrative Ductal Carcinoma-A Histopathological Study.

Authors:  Miguel A Ortega; Oscar Fraile-Martinez; Cielo García-Montero; Sandra Borja-Vergel; Diego Torres-Carranza; Leonel Pekarek; Coral Bravo Arribas; Juan A De León-Luis; Cristina Sánchez-Rojo; Miguel Angel Alvarez-Mon; Natalio García-Honduvilla; Julia Buján; Santiago Coca; Melchor Alvarez-Mon; Miguel A Saez; Luis G Guijarro
Journal:  Medicina (Kaunas)       Date:  2022-05-28       Impact factor: 2.948

2.  Interleukin-6 Signaling in Triple Negative Breast Cancer Cells Elicits the Annexin A1/Formyl Peptide Receptor 1 Axis and Affects the Tumor Microenvironment.

Authors:  Lara Vecchi; Sara Teixeira Soares Mota; Mariana Alves Pereira Zóia; Isabella Castro Martins; Jessica Brito de Souza; Tiago Góss Santos; Adriano de Oliveira Beserra; Victor Piana de Andrade; Luiz Ricardo Goulart; Thaise Gonçalves Araújo
Journal:  Cells       Date:  2022-05-20       Impact factor: 7.666

3.  MicroRNA-301a-3p promotes triple-negative breast cancer progression through downregulating MEOX2.

Authors:  Heng Liu; Gangyue Wang
Journal:  Exp Ther Med       Date:  2021-07-01       Impact factor: 2.447

4.  Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database.

Authors:  Zhuowei Tang; Yuzhu Ji; Yu Min; Xiaohong Zhang; Weiyun Xu; Lijuan Zhao; Jing Zhang; Li Long; Jing Feng; Yixue Wen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

5.  Unsupervised Hierarchical Classification Approach for Imprecise Data in the Breast Cancer Detection.

Authors:  Mario Fordellone; Paolo Chiodini
Journal:  Entropy (Basel)       Date:  2022-07-03       Impact factor: 2.738

6.  Body composition change during neoadjuvant chemotherapy for breast cancer.

Authors:  Min Kyeong Jang; Seho Park; Chang Park; Ardith Z Doorenbos; Jieon Go; Sue Kim
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

7.  Antioxidant, Anti-Proliferative Activity and Chemical Fingerprinting of Centaurea calcitrapa against Breast Cancer Cells and Molecular Docking of Caspase-3.

Authors:  Mourad A M Aboul-Soud; Hanane Ennaji; Ashok Kumar; Mohammad A Alfhili; Ahmed Bari; Maqusood Ahamed; Mohamed Chebaibi; Mohammed Bourhia; Farid Khallouki; Khalid M Alghamdi; John P Giesy
Journal:  Antioxidants (Basel)       Date:  2022-08-03

8.  Chloride Intracellular Channel 1 is a Potential Biomarker for Breast Cancer.

Authors:  Jinwen Xia; Quhui Wang; Fei Ju; Xiang Luo; Feng Wang; Youlang Zhou; Hua Huang; Hua Wang; Xingli Bao
Journal:  Breast Cancer (Dove Med Press)       Date:  2022-09-02

Review 9.  Key Factor Regulating Inflammatory Microenvironment, Metastasis, and Resistance in Breast Cancer: Interleukin-1 Signaling.

Authors:  Fengjie Liu; Lihong Li; Meng Lan; Tengteng Zou; Zhaodi Kong; Tiange Cai; Xiao Yu Wu; Yu Cai
Journal:  Mediators Inflamm       Date:  2021-09-23       Impact factor: 4.711

10.  Cancer-Specific Survival Outcome in Early-Stage Young Breast Cancer: Evidence From the SEER Database Analysis.

Authors:  Rui Liu; Zhesi Xiao; Daixing Hu; Haojun Luo; Guobing Yin; Yang Feng; Yu Min
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-18       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.